Results 231 to 240 of about 10,191,062 (296)

Cardiovascular Toxicity Associated With Bispecific Antibodies in Hematological Malignancies: A Comprehensive Pharmacovigilance Analysis

open access: yesAmerican Journal of Hematology, Volume 101, Issue 10, Page 2546-2556, October 2026.
ABSTRACT Cardiovascular adverse events (CVAEs) associated with bispecific T‐cell engaging antibodies (BsAbs) have not been systematically investigated across approved agents. In this disproportionality analysis of FAERS (December 2014–September 2025), reports listing BsAbs as the primary suspected drug (n = 7647) were compared with all other drugs in ...
Malak Munir   +9 more
wiley   +1 more source

Breast Mass as an Atypical Presentation of Non-Hodgkin Lymphoma. [PDF]

open access: yesCureus
Figueiredo F   +4 more
europepmc   +1 more source

A Multi-Targeted Strategy for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: Real-World Outcomes of the ViPOR Regimen. [PDF]

open access: yesJ Clin Med
Yiğit Kaya S   +7 more
europepmc   +1 more source

[Hodgkin lymphoma and non-Hodgkin lymphoma].

open access: yes[Rinsho ketsueki] The Japanese journal of clinical hematology, 2013
openaire   +2 more sources

Pediatric Mediastinal Gray Zone Lymphoma With Germline TET2 Heterozygous Variant

open access: yes
Pediatric Blood &Cancer, Volume 73, Issue 11, November 2026.
Matthew R. Schuelke   +9 more
wiley   +1 more source

Geospatial Access to CAR-T Clinical Trials for Non-Hodgkin Lymphoma for Persons With HIV.

open access: yesJAMA Netw Open
Maillie L   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy